The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs
- 1 November 1994
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 15 (11) , 405-406
- https://doi.org/10.1016/0165-6147(94)90083-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Novel nonsterodial anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the ratPublished by Elsevier ,1994
- A diclofenac derivative without ulcerogenic propertiesEuropean Journal of Pharmacology, 1994
- Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.Journal of Clinical Investigation, 1994
- Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cellsKidney International, 1994
- Effects of Transforming Growth Factor β and Interleukin-1β on Expression of Cyclooxygenase 1 and 2 and Phospholipase A2 mRNA in Lung Fibroblasts and Endothelial Cells in CultureBiochemical and Biophysical Research Communications, 1993
- Interleukin-1 Differentially Modulates Chondrocyte Expression of Cyclooxygenase-2 and Phospholipase A2Experimental Cell Research, 1993
- Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugsDrug Development Research, 1992
- Diclofenac delays healing of gastroduodenal mucosal lesionsDigestive Diseases and Sciences, 1991
- Nonsteroidal Anti-inflammatory Drugs and Peptic Ulcer DiseaseAnnals of Internal Medicine, 1991
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971